By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CURE Pharma 

1620 Beacon Place

Oxnard  California  93033 
Phone: 805-824-0410 Fax: 805-487-7163


CURE is a preeminent developer and manufacturer of the most advanced oral thin film (CureFilm™) on the market today with an industry leading full service cGMP manufacturing facility. CURE offers the most advanced development and manufacturing of CureFilm™ pharmaceutical and veterinarian products in a patented and proprietary delivery system.


CEO: Robert Davidson

CSO: Edward Maliski

COO: Wayne Nasby

CFO: Mark Udell


Key Statistics

Ownership: Private

Web Site: CURE Pharma


Company News
CURE Pharma Launches New Academic Partnership Program Providing The Company’s Proprietary Curefilm For More Humane And Effective Animal Research 9/6/2017 8:47:54 AM
CURE Pharma Subsidiary, Oak Therapeutics, Completes Critical Milestone In Phase I Of NIH Grant To Develop Oral Dissolvable Strip For Tuberculosis 8/23/2017 8:20:15 AM
CURE Pharma Enters Partnership To Distribute New Erectile Dysfuntion Drug Using Company’s Proprietary CureFilm Into Asian Market 8/10/2017 11:34:17 AM
CURE Pharma And Therapix Signs MOU With Israel’s Assuta Medical Centers To Develop First-In-Class Therapeutic Products In Fields Of Personalized Medicine & Cannabinoids 7/11/2017 10:25:52 AM
CURE Pharma & Therapix Signs MOU With Israel's Assuta Medical Center To Develop First-In-Class Therapeutic Products In Fields Of Personalized Medicine & Cannabinoids 7/11/2017 7:57:23 AM
CURE Pharma Expects Increased Demand For Its Enhanced Transdermal Drug Delivery Platform 7/5/2017 7:54:08 AM
CURE Pharma Appoints Cannakids CEO And Cannabis Cancer Advocate Tracy Ryan To Advisory Board 6/27/2017 7:50:49 AM
Leading OTF Manufacturer CURE Pharma Comments On New Report Showing Exponential Growth In Thin Film Drug Manufacturing Market 6/8/2017 12:14:27 PM
CURE Pharma And CannaKids Announce Research Collaboration With Technion-Israel Institute Of Technology On Cancer-Fighting Cannabinoids 5/31/2017 8:17:15 AM
CURE Pharma Receives First Purchase Order Stemming From Product Development And License Agreement With Pharmaceutical Company, Meroven 5/24/2017 9:41:00 AM